Outcomes of Patients With Double-Hit Lymphoma Who Achieve First Complete Remission Disease relapse remains a major challenge to successful outcomes in patients who undergo allogeneic hematopoietic ...
Philadelphia, February 24, 2023—Researchers at Children’s Hospital of Philadelphia (CHOP) have identified variants of a chaperone molecule that optimizes the binding and presentation of foreign ...
Researchers at Children's Hospital of Philadelphia (CHOP) have identified variants of a chaperone molecule that optimizes the binding and presentation of foreign antigens across the human population, ...
Researchers at Children’s Hospital of Philadelphia (CHOP) have identified variants of a chaperone molecule known as TAPBPR that optimizes the binding and presentation of foreign antigens across the ...
NOVEMBER 10, 2022—For the first time, scientists have used CRISPR technology to insert genes that allow immune cells to focus their attack on cancer cells, potentially leaving normal cells unharmed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback